Two drugmakers are appealing a Washington, D.C. federal district judge's ruling against unilateral 340B rebate models.

Two Drugmakers Appeal Federal District Judge’s 340B Rebate Ruling in Favor of HHS

Novartis and Bristol Myers Squibb (BMS) are both asking a federal appeals court to overturn a lower court’s ruling that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
LinkedIn

Site Footer Live